Stem, Inc. (NYSE:STEM) Given Consensus Rating of “Reduce” by Brokerages

Stem, Inc. (NYSE:STEM) has earned a consensus rating of “Reduce” from the five research firms that are currently covering the stock, Marketbeat reports. One analyst has rated the stock with a sell rating and four have issued a hold rating on the company. The average 1-year price objective among brokers that have issued a report on the stock in the last year is $7.45.

Several analysts have commented on STEM shares. Weiss Ratings cut shares of Stem from a “sell (d+)” rating to a “sell (e+)” rating in a research note on Tuesday, August 18th. Roth Capital reiterated a “neutral” rating and issued a $6.75 price objective on shares of Stem in a research note on Monday, August 17th. Wall Street Zen raised shares of Stem from a “strong sell” rating to a “sell” rating in a report on Saturday, August 15th. UBS Group restated a “neutral” rating and set a $7.00 target price (down from $10.50) on shares of Stem in a research report on Friday, August 14th. Finally, New Street Research set a $8.00 price target on shares of Stem in a report on Monday, July 27th.

Stem Stock Up 0.5%

Shares of NYSE:STEM opened at $5.69 on Friday. Stem has a 52-week low of $4.92 and a 52-week high of $32.23. The stock has a market cap of $54.77 million, a price-to-earnings ratio of -0.67 and a beta of 1.50. The business has a 50-day moving average price of $6.38 and a 200-day moving average price of $8.69.

Stem (NYSE:STEM) last issued its earnings results on Wednesday, August 12th. The company reported ($1.58) EPS for the quarter, beating analysts’ consensus estimates of ($1.75) by $0.17. The firm had revenue of $33.65 million during the quarter, compared to analysts’ expectations of $36.65 million. As a group, equities analysts anticipate that Stem will post -7.04 EPS for the current fiscal year.

Hedge Funds Weigh In On Stem

Several institutional investors and hedge funds have recently modified their holdings of STEM. AQR Capital Management LLC boosted its stake in shares of Stem by 505.8% in the first quarter. AQR Capital Management LLC now owns 1,482,790 shares of the company’s stock worth $519,000 after buying an additional 1,238,012 shares during the last quarter. Bank of America Corp DE raised its position in Stem by 104.0% during the third quarter. Bank of America Corp DE now owns 217,871 shares of the company’s stock valued at $3,817,000 after acquiring an additional 111,068 shares in the last quarter. Two Sigma Investments LP lifted its holdings in Stem by 461.9% in the third quarter. Two Sigma Investments LP now owns 94,045 shares of the company’s stock valued at $1,648,000 after acquiring an additional 77,307 shares during the period. GSA Capital Partners LLP lifted its holdings in Stem by 569.1% in the fourth quarter. GSA Capital Partners LLP now owns 79,216 shares of the company’s stock valued at $1,192,000 after acquiring an additional 67,377 shares during the period. Finally, Bridgeway Capital Management LLC boosted its position in Stem by 346.2% in the 4th quarter. Bridgeway Capital Management LLC now owns 69,600 shares of the company’s stock worth $1,047,000 after purchasing an additional 54,000 shares in the last quarter. Institutional investors and hedge funds own 61.63% of the company’s stock.

Key Stem News

Here are the key news stories impacting Stem this week:

• Positive Sentiment: Analysts’ average price target implies approximately 32.8% upside for Stem, Inc. (STEM). The article notes that upward earnings-estimate revisions are generally a more useful signal than price targets themselves, but the consensus still provides a potential catalyst for the stock. Wall Street Analysts See a 32.8% Upside in Stem
• Positive Sentiment: Separate analyst coverage places Stem’s consensus price target at $7.45, above its recent trading level. This supports the view that analysts see recovery potential, although the target is not a guarantee of future performance. Stem Receives $7.45 Consensus Price Target
• Neutral Sentiment: Several articles discuss education grants, after-school programs and efforts to maintain children’s interest in science, technology, engineering and mathematics. These developments are unrelated to Stem, Inc.’s energy-storage and software business and are unlikely to materially affect STEM shares. Oklahoma FFA STEM Grants
• Neutral Sentiment: Other reports cover stem-cell research, including potential treatments for heart disease, Parkinson’s disease and vision disorders. These are medical developments involving stem cells, not Stem, Inc., and should not be interpreted as news about the company. Stem Cells and New Treatments

About Stem

Stem, Inc is a technology company specializing in AI-driven energy storage and optimization solutions for commercial, industrial and utility customers. The company delivers integrated hardware and software systems that enable clients to manage energy consumption, reduce peak demand charges and provide ancillary services to the power grid. By combining battery storage hardware with advanced machine-learning algorithms, Stem helps organizations align energy usage with cost-saving opportunities while supporting grid reliability and renewable integration.

At the core of Stem’s offering is its Athena software platform, which uses real-time data and predictive analytics to forecast energy needs and automatically dispatch stored energy when it is most valuable.